Analyst Reco. Exscientia plc

Equities

EXAI

US30223G1022

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
5.39 ^USD	+1.51%		+7.16%	-15.91%

11/06	Transcript : Exscientia plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 03:20 PM
06/06	Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Barclays Cuts Price Target on Exscientia to $10 From $12, Maintains Overweight Rating	17/23/17	MT
Morgan Stanley Cuts Exscientia Price Target to $7 From $14, Maintains Equal Weight Rating	10/23/10	MT
Berenberg Bank Adjusts Exscientia to $10 From $14, Maintains Buy Rating	09/23/09	MT
Berenberg Initiates Exscientia With Buy Rating, $13 Price Target	21/23/21	MT
Morgan Stanley Adjusts Exscientia's Price Target to $14 From $15, Keeps Equalweight Rating	10/23/10	MT
UK Sping Budget Announcements Unlikely to Affect BOE Rate Decision	15/23/15	DJ
Barclays Lowers Price Target on Exscientia to $12 From $40, Maintains Overweight Rating	16/22/16	MT
Morgan Stanley Adjusts Price Target on Exscientia to $15 From $18, Maintains Equalweight Rating	09/22/09	MT
Morgan Stanley Cuts Price Target on Exscientia to $15 From $18, Maintains Equalweight Rating	09/22/09	MT
Morgan Stanley Adjusts Exscientia's Price Target to $18 From $20, Retains Equalweight Rating	24/22/24	MT
Goldman Sachs Adjusts Price Target on Exscientia to $18 From $20, Maintains Buy Rating	19/22/19	MT
Morgan Stanley Adjusts Exscientia Price Target to $20 From $21, Maintains Equal Weight Rating	13/22/13	MT
Goldman Sachs Adjusts Exscientia's Price Target to $20 from $23, Keeps Buy Rating	24/22/24	MT
Morgan Stanley Adjusts Exscientia's Price Target to $21 from $20, Keeps Equalweight Rating	11/22/11	MT
Morgan Stanley Starts Exscientia at Equal-Weight With $25 Price Target	26/21/26	MT
BofA Securities Starts Exscientia at Buy With $27 Price Target	26/21/26	MT
Goldman Sachs Starts Exscientia at Buy With $30 Price Target	26/21/26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer